CompletedNot Applicable

Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)

China1,176 participantsStarted 2022-08-01

Plain-language summary

The purpose of this study was to evaluate the detection ability of Helicobacter pylori 23S rRNA/gyrA gene mutation detection kit (fluorescent PCR fusion curve method) for Helicobacter pylori gene mutation.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\. patients with Helicobacter pylori infection who need gastroscopy; 2. patients with positive Helicobacter pylori culture in gastric mucosa 3. Helicobacter pylori negative patients Exclusion Criteria: * 1.Patients with insufficient fecal samples collected 2.Patients with contraindication of gastroscopic biopsy

What they're measuring

Evaluation of consistency between fecal gene detection kit and Drug sensitivity test

Timeframe: 4 weeks

Evaluation of consistency between fecal gene detection kit and first generation sequencing

Timeframe: 4 weeks

Trial details

NCT IDNCT05410652

SponsorNanjing First Hospital, Nanjing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-12

View on ClinicalTrials.gov More Helicobacter Pylori Infection trials